糖尿病合并新冠肺炎患者白细胞介素-6、白细胞介素-8、白细胞介素-10、TNF-α水平分析
Analysis of Interleukin-6, Interleukin-8, Interleukin-10 and TNF-α Levels in Patients with Diabetes Mellitus Complicated with New Crown Pneumonia
DOI: 10.12677/ACM.2021.115292, PDF,   
作者: 刘明阳, 翁韵琦*：青岛大学附属医院急诊内科，山东 青岛；石庚玉：青岛大学附属医院重症医学科，山东 青岛
关键词: 糖尿病；新冠肺炎；白细胞介素-6；白细胞介素-8；白细胞介素-10；TNF-α；Diabetes； New Crown Pneumonia； Interleukin-6； Interleukin-8； Interleukin-10； TNF-α
摘要: 目的：探讨分析糖尿病合并新冠肺炎患者白细胞介素-6、白细胞介素-8、白细胞介素-10、TNF-α水平情况。方法：选取青岛大学附属医院援鄂医疗队在华中科技大学附属同济医院光谷院区2020年2月9日至2020年3月31日收治新冠病毒肺炎(COVID-2019)患者中75例，依据是否合并糖尿病分为COVID-2019组(n = 56)、合并组(n = 19)，对比两组患者IL-6、IL-8、IL-10以及TNF-α指标水平。结果：两组患者IL-8、TNF-α指标对比无明显差异(P > 0.05)；合并组患者IL-6、IL-10指标相比COVID-2019组明显更高(P < 0.05)。结论：COVID-2019合并糖尿病患者IL-8以及TNF-α指标与未合并糖尿病患者对比无显著差异，但合并组患者的IL-6、IL-10指标水平更高。
Abstract: Objective: To investigate and analyze the levels of interleukin-6, interleukin-8, interleukin-10 and TNF-α in patients with diabetes complicated with new crown pneumonia. Methods: Seventy-five patients with newly diagnosed coronavirus pneumonia (COVID-2019) admitted by the Hubei Medical Team of the Affiliated Hospital of Qingdao University from February 9, 2020 to March 31, 2020 in the Guanggu Hospital of tongji hospital, affiliated to Huazhong University of Science and Technology were selected and divided into COVID-2019 group (n = 56) and combined group (n = 19) according to whether diabetes was complicated. The IL-6, IL-8, IL-10 and TNF-α index levels of the two groups of patients were compared. Results: There was no significant difference in the IL-8 and TNF-α indexes between the two groups of patients (P > 0.05); the IL-6 and IL-10 indexes of the patients in the combined group were significantly higher than those in the COVID-2019 group (P < 0.05). Conclusion: there is no significant difference in IL-8 and TNF-α indexes between COVID- 2019 patients with diabetes and patients without diabetes, but the level of IL-6, IL-10 indexes in patients with diabetes is higher.
文章引用：刘明阳, 石庚玉, 翁韵琦. 糖尿病合并新冠肺炎患者白细胞介素-6、白细胞介素-8、白细胞介素-10、TNF-α水平分析[J]. 临床医学进展, 2021, 11(5): 2043-2047. https://doi.org/10.12677/ACM.2021.115292

参考文献

[1] 钟久昌. 血管紧张素转换酶2: 新型冠状病毒肺炎炎症风暴的“导火索”和“灭火器” [J]. 中华高血压杂志, 2020, 28(3): 213-215.
[2] 杨晨茜, 瞿娇, 刘怡彤, 孟思伟, 王冰琳, 冯美卿, 孙洋. 新型冠状病毒肺炎的免疫失衡及干预策略[J]. 中国药理学通报, 2020, 36(4): 445-453.
[3] 唐劲松, 宣春, 林景涛, 张二盈, 钟孟如, 邓娟. C-反应蛋白、白介素-6及降钙素原检测在新冠肺炎中的临床意义[J]. 实用医学杂志, 2020, 36(7): 839-841.
[4] Patel, U., Malik, P., Mehta, D., Shah, D., Kelkar, R., Pinto, C., et al. (2020) Early Epidemiological Indicators, Outcomes, and Interventions of COVID-19 Pandemic: A Systematic Review. Journal of Global Health, 10, Article ID: 020506. [Google Scholar] [CrossRef] [PubMed]
[5] Han, H., Ma, Q., Li, C., Liu, R., Zhao, L., Wang, W., et al. (2020) Profiling Serum Cytokines in COVID-19 Patients Reveals IL-6 and IL-10 Are Disease Severity Predictors. Emerging Microbes & Infections, 9, 1123-1130. [Google Scholar] [CrossRef] [PubMed]
[6] Cai, Q., Huang, D., Ou, P., Yu, H., Zhu, Z., Xia, Z., et al. (2020) COVID-19 in a Designated Infectious Diseases Hospital Outside Hubei Province, China. Allergy, 75, 1742-1752. [Google Scholar] [CrossRef] [PubMed]
[7] Turnquist, C., Ryan, B.M., Horikawa, I., Harris, B.T. and Harris, C.C. (2020) Cytokine Storms in Cancer and COVID-19. Cancer Cell, 38, 598-601. [Google Scholar] [CrossRef] [PubMed]
[8] 赵勇, 谢敏, 李会敏, 徐敏芳, 夏方妹, 肖红慧. 2型糖尿病合并新型冠状病毒肺炎患者的临床特征及中医病机分析[J]. 湖北中医药大学学报, 2020, 22(4): 100-104.
[9] Elnour, A.A., Don, J., Yousif, I., Gnana, K., Abdi, S., Alhajri, N., et al. (2020) The Early Mortality Rate of People Infected with Coronavirus (COVID-2019) in Wuhan, China: Review of Three Retrospective Studies. Journal of Pharmacy and BioAllied Sciences, 12, 223-233. [Google Scholar] [CrossRef] 
[10] Biswas, M., Rahaman, S., Biswas, T.K., Haque, Z. and Ibrahim, B. (2020) Association of Sex, Age, and Comorbidities with Mortality in COVID-19 Patients: A Systematic Review and Meta-Analysis. Intervirology, 9, 36-47. [Google Scholar] [CrossRef] [PubMed]
[11] 魏东, 李颖, 刘蕾, 王毅. 纤维支气管镜吸痰联合抗感染对重症肺炎患者治疗效果及PCT、IL-6、CRP水平的影响[J]. 中国医刊, 2018, 53(4): 394-397.
[12] 唐智敏, 高湲, 杨世忠. 血清suPAR、D-二聚体及IL-6在重症肺炎患者中的表达及临床意义[J]. 临床肺科杂志, 2018, 23(9): 1691-1695.
[13] Rodrigues, K.F., Pietrani, N.T. and Bosco, A.A. (2017) IL-6, TNF-α, and IL-10 Levels/Polymorphisms and Their Association with Type 2 Diabetes Mellitus and Obesity in Brazilian Individuals. Archives of Endocrinology and Metabolism, 61, 438-446. [Google Scholar] [CrossRef] [PubMed]
[14] Sangoi, M.B., Carvalho, J.A.M., Guarda, N.S., Duarte, T., Duarte, M.M.M.F., Premaor, M.O., et al. (2019) Association between Urinary Levels of Interleukin-6, Interleukin-10 and Tumor Necrosis Factor-Alpha with Glomerular and Tubular Damage Indicators in Patients with Type 2 Diabetes. Clinical Laboratory, 65. [Google Scholar] [CrossRef] 
[15] Canecki-Varžić, S., Prpić-Križevac, I., Mihaljević, S., Bilić-Ćurčić, I., Alkhamis, T., Wagner, J., et al. (2018) Association Between Interleukin-10 Gene (-1082g/A) Polymorphism and Type 2 Diabetes, Diabetes-Related Traits, and Microvascular Complications in the Croatian Population. Acta Clinica Croatica, 57, 71-81. [Google Scholar] [CrossRef] [PubMed]
[16] Borowska, M., Dworacka, M., Wesołowska, A., Winiarska, H., Krzyżagórska, E. and Dworacki, G. (2016) The Impact of Pharmacotherapy of Type 2 Diabetes Mellitus on IL-1beta, IL-6 and IL-10 Secretion. Pharmacology, 97, 189-194. [Google Scholar] [CrossRef] [PubMed]
[17] Boyko, V.V. and Riga, A.S. (2020) Type 2 Diabetes Mellitus—IL-8 and IL-10 Profile in Patients with Intraabdominal Postoperative Abscesses. Wiadomości Lekarskie, 73, 220-223. [Google Scholar] [CrossRef] 
[18] Costa, F.F., Rosário, W.R., Ribeiro Farias, A.C., de Souza, R.G., Duarte Gondim, R.S. and Barroso, W.A. (2020) Metabolic Syndrome and COVID-19: An Update on the Associated Comorbidities and Proposed Therapies. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 14, 809-814. [Google Scholar] [CrossRef] [PubMed]
[19] Yang, A.P., Li, H.M., Tao, W.Q., Yang, X.J., Wang, M., Yang, W.J. and Liu, J.P. (2020) Infection with SARS-CoV-2 Causes Abnormal Laboratory Results of Multiple Organs in Patients. Aging, 12, 10059-10069. [Google Scholar] [CrossRef] [PubMed]
[20] Ouyang, Y., Yin, J., Wang, W., Shi, H., Shi, Y., Xu, B., et al. (2020) Downregulated Gene Expression Spectrum and Immune Responses Changed during the Disease Progression in Patients with COVID-19. Clinical Infectious Diseases, 71, 2052-2060. [Google Scholar] [CrossRef] [PubMed]

为你推荐